Format

Send to

Choose Destination
Nat Protoc. 2014 Dec;9(12):2823-40. doi: 10.1038/nprot.2014.187. Epub 2014 Nov 13.

CRISPR/Cas9-mediated conversion of eGFP- into Gal4-transgenic lines in zebrafish.

Author information

1
1] Institut Curie, Centre de Recherche, Paris, France. [2] Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3215, Paris, France. [3] Institut National de la Santé de la Recherche Médicale (INSERM) U934, Paris, France. [4] Centre for Organismal Studies Heidelberg, University of Heidelberg, Heidelberg, Germany.
2
1] Institut Curie, Centre de Recherche, Paris, France. [2] Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3215, Paris, France. [3] Institut National de la Santé de la Recherche Médicale (INSERM) U934, Paris, France.
3
1] Muséum National d'Histoire Naturelle, Paris, France. [2] CNRS UMR 7196, Paris, France. [3] INSERM U1154, Paris, France.

Abstract

Here we present a protocol for the conversion of eGFP-transgenic zebrafish lines into lines expressing Gal4 from the same locus. This conversion allows the in-depth analysis of the former eGFP-expressing cell population; with the Gal4-upstream activating sequence (UAS) system, diverse UAS transgenes can be transactivated. Site-specific targeting of the gene encoding eGFP is achieved using the clustered regularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/Cas9) system. A single-guide RNA (sgRNA) that targets eGFP is injected into embryos together with a donor vector containing an optimized version of Gal4 (KalTA4) to trigger integration of the donor into the targeted eGFP genomic location. To enable screening for successful integration events, injection is performed in a UAS:RFP transgenic background; fish showing mosaic eGFP-to-RFP conversion are raised to adulthood. The progeny of these adult fish are then screened for stable germline transmission, and converted progeny are used to generate stable lines. We have been able to generate two stably converted transgenic lines within 4 months.

PMID:
25393779
DOI:
10.1038/nprot.2014.187
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center